UnknownPhase 3NCT00487253

Oral Miltefosine for the Treatment of Pediatric Cutaneous Leishmaniasis in Colombia

Studying Leishmaniasis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Centro Internacional de Entrenamiento e Investigaciones Médicas
Principal Investigator
Luisa Consuelo Rubiano, MD, MSc
Centro Internacional de Entrenamiento e Investigaciones Médicas
Intervention
Miltefosine(drug)
Enrollment
150 enrolled
Eligibility
2-12 years · All sexes
Timeline
2007 – 2010

Collaborators

Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnología (COLCIENCIAS) · INS · Instituto Nacional de Dermatología Centro dermatológico Federico Lleras Acosta

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00487253 on ClinicalTrials.gov

Other trials for Leishmaniasis

Additional recruiting or active studies for the same condition.

See all trials for Leishmaniasis →

← Back to all trials